Innovus Pharmaceuticals

Innovus Pharmaceuticals has 14 on-market SKUs in the DSLD, first entered 2018-10-25. 42.9% of its products declare at least one proprietary blend, and 6.7% of all its all-time SKUs are now off-market.

Report card

• Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): 1.5
• % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 14.3%
• Average excipient count per product: 4
• First entry: 2018-10-25 · Latest entry: 2024-01-24
• Mineral/vitamin rows by quality tier: tier 1: 25%, tier 2: 12.5%, tier 3: 25%, unrated: 37.5%

Products (15)